CapsoVision (CV) Free Cash Flow (2024 - 2025)
CapsoVision (CV) reported Free Cash Flow of -$7.7 million for Q4 2025, down 46.54% on a YoY basis from -$14.4 million in Q4 2024, and down 35.65% sequentially from -$5.7 million in Q3 2025.
CapsoVision (CV) Free Cash Flow (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Free Cash Flow data on file, last reported at -$7.7 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 46.54% year-over-year to -$7.7 million; the trailing twelve-month figure through Dec 2025 stood at -$18.6 million (changed N/A YoY), and the FY2025 full-year result was -$22.9 million, down 13.81% from the prior year.
- Free Cash Flow declined to -$7.7 million in Q4 2025, from -$5.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$5.2 million in Q4 2024 to a low of -$7.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | -7.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.69 Mn |
| Dec 31, 2025 | -7.69 Mn |
| Sep 30, 2025 | -5.67 Mn |
| Sep 30, 2025 | -5.67 Mn |
| Dec 31, 2024 | -5.25 Mn |
| Dec 31, 2024 | -5.25 Mn |
| Sep 30, 2024 | -7.21 Mn |
| Sep 30, 2024 | -7.21 Mn |